U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Abdul El-Sayed Wins Michigan Democratic Senate Primary, Sets Up Key Midterm Showdown
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
U.S. Unseals Charges Against Five Alleged CJNG Leaders, Raises Reward for New Cartel Chief
US Continues Ukraine Patriot Missile Production Talks Despite Trump Doubts
Trump Faces Tough Choices as Iran War Drags On
Bezalel Smotrich Faces Election Battle as Israel’s Far-Right Vote Fractures
Zelensky Urges Faster NATO Action on Air Defense Missiles
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing
New Zealand MMP Electoral System Faces Fresh Referendum Debate
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Rubio, UK’s Miliband Stress Stronger European Security Role in Washington Talks
North Korea May Deploy 120 Missiles to Russia 



